News & Updates

Alogliptin ups risk of heart failure exacerbation in T2D patients
Alogliptin ups risk of heart failure exacerbation in T2D patients
13 Mar 2024

In type 2 diabetes (T2D) patients with established heart failure (HF), use of alogliptin appears to contribute to an increased risk of HF exacerbation, reveals a study.

Alogliptin ups risk of heart failure exacerbation in T2D patients
13 Mar 2024
High blood sugar predicts CV death in adults with or without hypertension
High blood sugar predicts CV death in adults with or without hypertension
12 Mar 2024

Age and the presence or absence of hypertension influences the effect of hyperglycaemia on cardiovascular death, suggesting the importance of case-specific risk assessments in middle-aged and older people, according to a study.

High blood sugar predicts CV death in adults with or without hypertension
12 Mar 2024